Clinical Trials Logo

Filter by:
NCT ID: NCT01891370 Completed - Pregnancy Clinical Trials

Median Study for Biochemical Serum Markers in First Trimester of Pregnancy

Start date: July 2013
Phase: N/A
Study type: Observational

The purpose of this study is to get initial values (normal medians) for certain biochemical serum markers for pregnancy weeks 10-13. Also initial values for mean arterial blood pressure measurement and certain ultrasound measurement may be established.

NCT ID: NCT01886547 Completed - Prostate Cancer Clinical Trials

2013 Annual National Digital Rectal Exam (DRE) Day Study

Start date: June 2013
Phase: N/A
Study type: Observational [Patient Registry]

We aim to determine the effectiveness of 2013 "Mag paDRE ka" programme in increasing general public awareness on prostate health and promoting prostate health assessment among Filipino males aged 40 or older.

NCT ID: NCT01880294 Completed - Constipation Clinical Trials

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

CONSIST
Start date: March 2013
Phase: Phase 4
Study type: Observational

The purpose of the study is to evaluate the differences or similarities in the results obtained with two different scoring systems for chronic constipation in Asian participants consulting in gastroenterology clinics (the Asian Neurogastro-enterology and Motility Association (ANMA) chronic constipation (CC) diagnostic tool (diagnosis questionnaire) and the ROME III diagnosis criteria (western gold standard).

NCT ID: NCT01876368 Completed - Hypertension Clinical Trials

Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan

Start date: September 2013
Phase: Phase 3
Study type: Interventional

This study will assess the efficacy and safety of LCZ696 in comparison to olmesartan in essential hypertensive patients not adequately responsive to olmesartan

NCT ID: NCT01867021 Completed - Influenza Clinical Trials

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Start date: May 2013
Phase: Phase 4
Study type: Interventional

Demonstrate non-inferiority of the post-vaccination (Day 22) Hemagglutination inhibition (HI) Geometric Mean Titers (GMTs) of trivalent, inactivated, subunit influenza vaccine (TIV) over the corresponding GMTs of the comparator vaccine for all three strains, in healthy adults aged 50 years and above. Demonstrate non-inferiority of the percentages of subjects achieving seroconversion in antibody titers at Day 22 in the TIV group over the corresponding percentages of subjects in the comparator group for all three strains, in healthy adults aged 50 years and above.

NCT ID: NCT01862341 Completed - Constipation Clinical Trials

The Effect of Milk Powder With Fiber and Probiotics on Digestive Habits and General Health Well-being of Selected Filipino Mothers.

Start date: May 2013
Phase: N/A
Study type: Interventional

In-Shape Nutritional Milk Powder is a nutritional milk powder containing fibers, probiotics and other nutrients. This study will focus on the effects of fiber and probiotics on digestive health and health well being in selected Filipino mothers

NCT ID: NCT01861600 Completed - Stool Composition Clinical Trials

Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas

Start date: April 2009
Phase: Phase 3
Study type: Interventional

The primary efficacy objective was to determine and compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) among the feeding groups.

NCT ID: NCT01859923 Completed - Clinical trials for Multidrug Resistant Tuberculosis

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Start date: July 20, 2013
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to assess the safety, tolerability, pharmacokinetics, and efficacy of long-term (6-month) treatment with delamanid plus an optimized background regimen (OBR) of other anti-tuberculosis drugs in pediatric participants who completed Study 242-12-232 (NCT01856634).

NCT ID: NCT01857206 Completed - Influenza Clinical Trials

Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy children and adolescents 4 to 17 years of age.

NCT ID: NCT01856634 Completed - Pediatric Clinical Trials

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Start date: June 14, 2013
Phase: Phase 1
Study type: Interventional

The purpose of this trial is to determine the pediatric dose of delamanid that is equivalent to the adult dose already shown to be effective against multidrug-resistant tuberculosis.